DCF — MARIA PARHAM MEDICAL CENTER
Enterprise Value: $-179.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-179.7M
Enterprise Value
$-57.5M
PV of Cash Flows
$-122.2M
PV of Terminal Value
$-196.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $131.8M | $-10.8M | -8.0% | $-16.4M | $-14.9M |
| Year 2 | $135.7M | $-9.8M | -7.0% | $-15.6M | $-12.9M |
| Year 3 | $139.8M | $-8.7M | -6.0% | $-14.6M | $-11.0M |
| Year 4 | $144.0M | $-8.2M | -6.0% | $-14.3M | $-9.8M |
| Year 5 | $148.3M | $-8.1M | -5.0% | $-14.4M | $-8.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-179.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$128.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08725800023947959
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5